J
Juhani Eskola
Researcher at National Institutes of Health
Publications - 115
Citations - 9737
Juhani Eskola is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Conjugate vaccine & Vaccination. The author has an hindex of 51, co-authored 114 publications receiving 9330 citations. Previous affiliations of Juhani Eskola include University of Helsinki & Sanofi Pasteur.
Papers
More filters
Journal ArticleDOI
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
Juhani Eskola,Terhi Kilpi,Arto A. Palmu,Jukka Jokinen,Haapakoski J,Herva E,A K Takala,Helena Käyhty,Pekka Karma,Robert Kohberger,George R. Siber,Mäkelä Ph +11 more
TL;DR: The heptavalent pneumococcal polysaccharide-CRM197 conjugate vaccine is safe and efficacious in the prevention of acute otitis media caused by the serotypes included in the vaccine.
Journal ArticleDOI
Addressing the vaccine confidence gap
TL;DR: The vaccine community demands rigorous evidence on vaccine efficacy and safety and technical and operational feasibility when introducing a new vaccine, but has been negligent in demanding equally rigorous research to understand the psychological, social, and political factors that affect public trust in vaccines.
Journal ArticleDOI
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Juhani Eskola,Helena Käyhty,A K Takala,Heikki Peltola,Pirjo-Riitta Rönnberg,E Kela,Pekkanen E,P H McVerry,Mäkelä Ph +8 more
TL;DR: A new conjugate vaccine consisting of the capsular polysaccharide of H. influenzae type b covalently linked to a protein carrier (PRP-D), administered to infants beginning at the age of 3 months, is highly effective in protecting young Finnish children (7 to 24 months old) against invasive H. Influenzaetype b infections.
Journal ArticleDOI
Global epidemiology of invasive meningococcal disease.
Rabab Z. Jafri,Asad Ali,Nancy E. Messonnier,Carol Tevi-Benissan,David N Durrheim,Juhani Eskola,Florence Fermon,Keith P. Klugman,Keith P. Klugman,Mary Ramsay,Samba O. Sow,Shao Zhujun,Zulfiqar A Bhutta,Jon S. Abramson +13 more
TL;DR: A review of the worldwide epidemiology of invasive meningococcal disease (IMD) varies markedly by region and over time and identifies the highest-incidence countries where routine preventive programs against Neisseria meningitidis would be most beneficial in providing protection.
Global epidemiology of invasive meningococcal disease
Rabab Z. Jafri,Asad Ali,Nancy E. Messonnier,Carol Tevi-Benissan,David N Durrheim,Juhani Eskola,Florence Fermon,Keith P. Klugman,Keith P. Klugman,Mary Ramsay,Samba O. Sow,Shao Zhujun,Zulfiqar A Bhutta,Jon S. Abramson +13 more
TL;DR: The burden of IMD in different countries is summarized and the highest-incidence countries where routine preventive programs against Neisseria meningitidis would be most beneficial in providing protection are identified.